Sign in
4

Changes in Ownership

Janux Therapeutics, Inc. Filed Acc 0001864159-26-000002

Chief Business Officer sold 1,879 shares at $13.73 ($25,799)

From the SEC's structured data for this filing

Trades in this filing

Meyer Andrew Hollman · Chief Business Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-01-02 Sale : show line 1 in the form −1,879 $13.73 $25,799 83,095 D
Open-market sales · 1,879 sh · avg $13.73 · $25,799
Loading xslF345X05/form4-01022026_090112.xml…